Xeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Highlights
Go back to Xeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Highlights| (NASDAQ: XERS) | Delayed: 8.80 +0.60 (7.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.20 | 52 Week High | $ | |||
| Open | $8.28 | 52 Week Low | $ | |||
| Day High | $8.81 | P/E | N/A | |||
| Day Low | $8.16 | EPS | $ | |||
| Volume | 3,231,367 | |||||

